164 related articles for article (PubMed ID: 6975547)
1. Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjects.
Heynen G; Cornet F; Franchimont P; Gaspar S; Plomteux G; Cession-Fossion G; Russel RG; Kanis JA
Acta Endocrinol (Copenh); 1981 Dec; 98(4):619-24. PubMed ID: 6975547
[TBL] [Abstract][Full Text] [Related]
2. Acute actions of 1,25-dihydroxy-vitamin D3 in normal man: effect on calcium and parathyroid status.
Llach F; Coburn JW; Brickman AS; Kurokawa K; Norman AW; Canterbury JM; Reiss E
J Clin Endocrinol Metab; 1977 Jun; 44(6):1054-60. PubMed ID: 194908
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Action of vitamin D metabolites on PTH secretion in man.
Miravet L; Guéris J; Redel J; Norman A; Ryckewaert A
Calcif Tissue Int; 1981; 33(3):191-4. PubMed ID: 6791781
[TBL] [Abstract][Full Text] [Related]
5. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
[TBL] [Abstract][Full Text] [Related]
6. Lack of effects of 1,25- and 24,25-dihydroxy vitamin D on parathyroid hormone response to hypocalcemia in cattle.
Voumard B; Trechsel U; Fischer JA; Blum JW
Metab Bone Dis Relat Res; 1984; 5(4):171-5. PubMed ID: 6429475
[TBL] [Abstract][Full Text] [Related]
7. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
8. Phosphatemic action of 1,25-dihydroxyvitamin D3.
Steele TH; Engle JE; Tanaka Y; Lorenc RS; Dudgeon KL; DeLuca HF
Am J Physiol; 1975 Aug; 229(2):489-95. PubMed ID: 1163676
[TBL] [Abstract][Full Text] [Related]
9. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
Brandi L; Egfjord M; Olgaard K
Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
Neer RM; Holick MF; DeLuca HF; Potts JT
Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134
[TBL] [Abstract][Full Text] [Related]
12. Lack of a direct effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by normal bovine parathyroid glands.
Golden P; Greenwalt A; Martin K; Bellorin-Font E; Mazey R; Klahr S; Slatopolsky E
Endocrinology; 1980 Aug; 107(2):602-7. PubMed ID: 6893023
[TBL] [Abstract][Full Text] [Related]
13. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
Marcus R; Orner FB; Brickman AS
Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of some hydroxylated vitamin D metabolites on parathyrin secretion by dispersed rat parathyroid cells in vitro.
Gruson M; Demignon J; Del Pino Montes J; Miravet L
Steroids; 1982 Sep; 40(3):275-85. PubMed ID: 6985176
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D3, 25-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion.
Cantley LK; Russell JB; Lettieri DS; Sherwood LM
Calcif Tissue Int; 1987 Jul; 41(1):48-51. PubMed ID: 3040201
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of active vitamin D preparations on PTH secretion in rats.
Kugai N; Koide Y; Kimura S; Yamashita K
Endocrinol Jpn; 1984 Apr; 31(2):151-8. PubMed ID: 6086295
[TBL] [Abstract][Full Text] [Related]
18. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
[TBL] [Abstract][Full Text] [Related]
19. Normal plasma calcium, phosphate, and parathyroid hormone levels during 1,25(OH)2D3 infusions in rats.
Fox J; Kollenkirchen U
Am J Physiol; 1992 Jan; 262(1 Pt 1):E126-9. PubMed ID: 1733243
[TBL] [Abstract][Full Text] [Related]
20. Interaction between 24R,25-dihydroxycholecalciferol and 1,25-dihydroxycholecalciferol on 45Ca release from bone in vitro.
Mahgoub A
Calcif Tissue Int; 1981; 33(6):663-6. PubMed ID: 6799176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
